Immediate Impact
2 from Science/Nature 54 standout
Citing Papers
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Works of John P. Crapanzano being referenced
PD‐L1 expression in non‐small cell lung carcinoma: Comparison among cytology, small biopsy, and surgical resection specimens
2017
Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinoma
2005
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| John P. Crapanzano | 604 | 178 | 497 | 203 | 45 | 1.0k | |
| Giuliana Sartori | 646 | 339 | 615 | 120 | 39 | 1.3k | |
| Paul Chih-Hsueh Chen | 481 | 245 | 316 | 124 | 47 | 999 | |
| Jay Wasman | 242 | 287 | 441 | 160 | 63 | 1.2k | |
| Lisa A. Cerilli | 382 | 412 | 422 | 144 | 37 | 1.2k | |
| Hajdu Si | 367 | 299 | 401 | 102 | 50 | 997 | |
| S. Franzén | 347 | 392 | 292 | 165 | 46 | 1.3k | |
| Thomas Dreyer | 328 | 420 | 454 | 80 | 54 | 1.2k | |
| J Høie | 423 | 380 | 293 | 148 | 46 | 1.1k | |
| Tamera J. Lillemoe | 357 | 136 | 441 | 162 | 28 | 1.0k | |
| Marius Lund‐Iversen | 516 | 119 | 490 | 158 | 58 | 985 |
All Works
Login with ORCID to disown or claim papers
Loading papers...